首页|IL-10基因位点rs1554286(G/A)多态性与延边地区原发性肝癌的预后分析

IL-10基因位点rs1554286(G/A)多态性与延边地区原发性肝癌的预后分析

扫码查看
目的:研究白细胞介素-10(IL-10)基因位点rs1554286(G/A)多态性与延边地区原发性肝癌(PHC)患者预后的相关性,为找寻可以预测PHC患者预后的生物标志物提供理论依据。方法:选取2003年11月~2015年11月在延边肿瘤医院和延边大学附属医院确诊为PHC的患者共191例。使用全血DNA提取试剂盒提取血液标本中的DNA样本。设计聚合酶链反应(PCR)引物,对含有单核苷酸多态性(SNP)位点的DNA模板进行扩增。采用核酸质谱分析系统(Massarray)SNP分型技术分析SNP位点的基因型。结果:(1)2组患者在年龄和性别构成方面差异无统计学意义(P>0.05)。(2)IL-10基因位点rs1554286有G和A两种等位基因,AA、GG、GA三种基因型。191例PHC患者的基因型分布频率符合哈迪-温伯格(H-W)遗传平衡定律差异无统计学意义(P>0.05)。(3)其中死亡组(154例),存活组(37例),2组患者之间是否有肝炎病史、是否手术2个因素具有统计学差异(P<0.05),年龄、性别、民族、饮酒、吸烟、肝癌分期6个因素差异无统计学意义(P>0.05)。(4)有肝炎病史、有手术史、低肝癌分期的PHC患者中位生存时间(MST)长差异具有统计学意义(P<0.05)。(5)显性模型显示:rs1554286 AA基因型PHC患者的MST比GG+GA基因型患者长差异具有统计学意义(P<0.05)。结论:(1)IL-10 rs1554286(G/A)SNP与延边地区PHC患者的预后相关,拥有rs1554286 A等位基因是延边地区PHC患者预后的保护性因素。(2)有肝炎病史的PHC患者比没有肝炎病史的预后好。
Association of IL-10 gene rs1554286 (G/A) polymorphism with prognosis of patients with primary hepatocellular carcinoma
Objective:To explore the association between the interleukin-10 (IL-10) gene single nucleotide polymorphism (SNP) rs1554286 (G/A) and the prognosis of patients with primary hepatic carcinoma (PHC) in Yanbian area, in order to provide theoretical basis for finding biomarkers that can predict the prognosis of PHC patients.Methods:From November 2003 to November 2015, a total of 191 patients with PHC were selected from Yanbian Tumor Hospital and Yanbian University Affiliated Hospital. DNA in blood samples was extracted using a whole blood DNA extraction kit. Polymerase chain reaction (PCR) primers were designed to amplify the DNA sequence containing the SNP site. Massarray SNP genotyping technology was used to analyze the genotype of the SNP site.Results:The IL-10 gene locus rs1554286 has G and A alleles and AA, GG, and GA genotypes. The genotype distribution frequency in the 191 patients with PHC was consistent with the law of Hardy-Weinberg equilibrium (P>0.05). There are 154 cases in the death group and 37 cases in the surviving group. There was a statistically significant difference in history of hepatitis and undergoing surgery or not between the two groups (P<0.05), but there was no significant difference in age, sex, ethnicity, drinking, smoking, or tumor stage between them (P>0.05). PHC patients with a history of hepatitis, surgery, and low tumor stage had a longer median survival time (P<0.05). The dominant model showed that the median survival time of PHC patients with rs1554286 AA genotype was longer than that of patients with GG+GA genotype (P<0.05).Conclusion:The IL-10 SNP rs1554286 (G/A) is associated with the prognosis of PHC patients. Having the rs1554286 A allele is a protective factor for the prognosis of PHC patients.

肖西洋、金光、孙润杰、崔鹤松

展开 >

133000 吉林延边,延边大学医学院附属医院感染科

原发性肝癌 单核苷酸多态性 中位生存时间

吉林省自然科学基金国家自然基金项目

YDZJ202301ZYTS19031460284

2023

中华临床医师杂志(电子版)
中华医学会

中华临床医师杂志(电子版)

CSTPCD
影响因子:0.99
ISSN:1674-0785
年,卷(期):2023.17(11)
  • 1